Oxford Finance, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, announced the closing of a $200 million senior unsecured note offering by Oxford and Oxford Finance Co-Issuer, Inc., a wholly owned subsidiary of Oxford. The notes bear interest at a fixed rate of 7.25% and mature in 2018. Oxford intends to use the net proceeds of this offering to repay a portion of its funding debt and to use the remainder, if any, for general corporate purposes.

The notes were offered in the United States to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, that are qualified purchasers, as defined in Section 2(a)(51) of the Investment Company Act of 1940, as amended.